-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Lymphoma Drug Details: Afatinib dimaleate (Giotrif, Gilotrif, Xovoltib)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Bile Duct Cancer (Cholangiocarcinoma) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Cutaneous Squamous Cell Carcinoma...
-
Product Insights
NewUNEEG Medical A/S Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our UNEEG Medical A/S Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. UNEEG Medical A/S (UNEEG Medical) is a developer of implants that monitor and analyse brain activity. The company offers EEG-based concept innovation, product development; data analysis, pattern recognition and algorithm development; clinical trials, regulatory affairs, and sales and marketing programs. Its products include tiny implant EEG monitoring device for diabetics suffering from unawareness to low blood sugar levels. UNEEG...
-
Company Insights
M-PESA – Competitor Profile
M-PESA is a mobile-based fund transfer and micro-level banking service available to customers of Safaricom, Kenya’s largest mobile network. Introduced in 2007, the service has become a primary channel for fund transfers in the country. Originally developed as a low-cost microfinance loan repayment system, it was extended as an open platform to remit funds and make consumer payments due to its rising popularity. This was largely a result of factors such as the high cost of remitting funds through banks,...
-
Sector Analysis
Hydrogen Transition Market Outlook and Trends, Deals, Contracts, Policies, Projects and Key Players, Q2 2024
Hydrogen Energy Transition Market Report Overview The total active and pipeline capacity of low-carbon hydrogen projects is 204 mtpa as of March 2024, of which 92% comes from green plants and the remaining from blue plants. The following are some of the key highlights of the hydrogen energy transition market: Countries with ample renewable resources are pursuing green hydrogen projects to capitalize on the falling cost of producing renewable energy. In Q1 2024, 7 countries announced new low-carbon hydrogen plants,...
-
Product Insights
Likelihood of Approval Analysis for Prader-Willi Syndrome (PWS)
Overview How likely is it that the drugs in Prader-Willi Syndrome (PWS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prader-Willi Syndrome (PWS) Overview Prader-Willi syndrome (PWS) is a rare congenital...
-
Product Insights
NewQuarterly Cookies (Sweet Biscuits) pricing trends in Saudi Arabia
Empower your strategies with our Quarterly Cookies (Sweet Biscuits) pricing trends in Saudi Arabia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewQuarterly Cookies (Sweet Biscuits) pricing trends in Japan
Empower your strategies with our Quarterly Cookies (Sweet Biscuits) pricing trends in Japan report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important...
-
Sector Analysis
Japan Green Buildings Market Summary, Competitive Analysis and Forecast to 2028
Green Buildings in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Green Buildings involve the design, construction, operation, and maintenance of buildings in an environmentally responsible and resource-efficient way. The goal of green buildings is to minimize a building's negative impact on the environment and...